UK buys anti-flu drugs for 14 million people
The UK government intends to purchase a stockpile of anti-flu drugs to treat 14.6 million people over the next two years as part of the UK's preparedness for an influenza pandemic.
Archives for March 2, 2005
Neurocrine announces positive GnRH receptor antagonist trials.
Neurocrine Biosciences has announced positive Phase I clinical trial results with its proprietary, orally active small molecule Gonadotropin-Releasing Hormone (GnRH) receptor antagonist that could diminish bone demineralisation.
Real time spectrometer unveiled by JEOL
JEOL USA has unveiled a new technology for analysing the chemical composition of solids, gases, and liquids in real time, with applications across a broad range of industries including the identification and tracing of pharmaceutical products.
Archimedes expands nasal analgesic alliance
UK company Archimedes Pharma has signed the first licensing deal for its nasal delivery platform since acquiring the technology from West Pharmaceutical Services last month.
Dutch scheme extends helping hand to biotech SMEs
The Netherlands has set up a programme to boost its biotechnology sector by helping small and medium-sized biopharma firms to develop and manufacture products, writes Phil Taylor.
JRH acquisition strengthens Sigma's strategy
Sigma-Aldrich has completed the acquisition of JRH Biosciences division (JRH) for $370 million (€282 million) in cash, extending its presence in the cell culture product sector and consolidating its position in the burgeoning functional genomics market.
Novel HIV therapy yields encouraging results
VIRxSYS report the results of its latest clinical trial, testing VRX496, a HIV-derived lentiviral vector that could represent a novel HIV gene therapy. The trial results also showed patients with multiple-drug resistant HIV responding well to the therapy.
Disposable mixer for bioprocessing launched
In the US, Wave Biotech and ILC Dover have launched a new version of their disposable mixing device for use in the pharmaceutical, biotechnology and other industries.
Niro extends drying test centre for pharma
Denmark-headquartered Niro is finalizing a €10 million investment programme centred on the expansion of its drying test site, located at its main facility in Copenhagen, that will extend its reach into the pharmaceutical sector, reports Phil Taylor.